Remedium Bio-Technology's approach to clinical research is clearly defied, and that is to fully explore innovative medicines that result in having a remarkable impact on people's lives. This is the reason for our success and why we're able to create value for both our patients, partners and our shareholders.
This unique and focused approach to our clinical research, in conjunction with our determination and innovation, allows us to develop differentiated products for the clinical and medical markets that benefit patients and health care providers alike. All of our employees, partners and investors around the world are united in the mission to deliver a remarkable and beneficial impact to patients' lives, and that of their families.
With our research we do far more than just treat diseases—we're committed to new thinking and approaches that will make for a greater impact to the medical profession and allow for greater client care and symptom relief.
Through our many and varied research programs we are developing a consistent stream of innovative new medicines, and through these programs we plan to launch 9 new products by 2020 that will further elevate the standard of medical care and create significant clinical advancements to patient care.
Our innovation-driven, patient-focused, bio-pharmaceutical expertise is proven to be capable of achieving a consistent stream of these new and innovative medicines, medicines that will address the world's pressing health challenges, not only those being faced today but also those in the years ahead.
We will continue to build on our market leadership and to bling our clinically beneficial products to patients around the world.
Our research, which has been key to our success thus far, will also be key to our future success.
To deliver innovative medicines and advance patient care
With a shared vision philosophy, we align our capabilities to conduct ground-breaking clinical proven, innovative medicines to societies around the globe.